相关实验视频
Updated: Jan 18, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
909
全球粮食政策与肥胖:从选定的国家经验中吸取教训
Esther Ugo Alum1,2, Ada Ak Akwari3,4, Muhammed Kibuuka5
1Department of Research and Publications, Kampala International University, Kampala, Uganda.
Food and nutrition bulletin
|January 16, 2026
概括
全球粮食政策在打击肥胖问题上扎,原因是行业的阻力和社会经济差异等障碍. 为了有效预防肥胖,需要针对超加工食品和营销的更协调,更公平的战略.
科学领域:
- 公共卫生 营养 公共卫生 营养
- 卫生政策 卫生政策
- 食品系统 食品系统
背景情况:
- 肥胖是一个由超加工食品驱动的全球危机,政策干预面临不均衡的进展.
- 社会经济,政治和行业障碍阻碍了全球有效的肥胖预防策略.
研究的目的:
- 审查全球粮食政策,以预防肥胖.
- 找出落实缺口,并建议采取公平,协调的行动.
- 检查健康食品环境的战略.
主要方法:
- 来自PubMed和Scopus (2017-2025) 的文献叙事评论.
- 包括同行评审的研究,政策文件和国际机构的报告.
- 关键词:全球粮食政策,预防肥胖,超加工食品,营养标签,糖税.
主要成果:
- 政策干预包括财政措施,标签,营销限制,UPF监管,食品服务,学校政策和国际协调.
- 包装前面的标签和含糖饮料税显示了区域性的有效性.
- 健康食品补贴看起来很有前途,特别是对于低收入群体,但由于差距和行业阻力,面临可扩展性问题.
结论:
- 目前的全球粮食政策不足以应对肥胖流行病.
- 转型型,多部门和以公平为重点的框架至关重要.
- 优先考虑UPF监管,标准化标签,营销控制,并将肥胖预防纳入卫生政策.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Regulation of Food Intake
2.3K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
Cancer Prevention
7.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.7K
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169

